Bortezomib: A New Promising Therapy for Early Antibody-Mediated Rejection After Liver Transplantation?

• Marcio F. Chedid, MD, PhD,
• Emilio Rodrigo, MD, PhD

Affiliations

Marcio F. Chedid, MD, PhD

1 Liver and Pancreas Transplant and Hepatobiliary Surgery Unit, Hospital de Clinicas de Porto Alegre, Medical School of UFRGS, Porto Alegre, Brazil.

Emilio Rodrigo, MD, PhD

3 Nephrology Department, Hospital Universitario Marqués de Valdecilla/IDIVAL, University of Cantabria, Santander, Spain.